| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 08/13/2009 | CA2713519A1 Amide derivatives as positive allosteric modulators and methods of use thereof |
| 08/13/2009 | CA2713347A1 Mesoionic pesticides |
| 08/13/2009 | CA2713173A1 (dihydro)pyrrolo[2,1-.alpha.]isoquinolines |
| 08/13/2009 | CA2712574A1 Polymorphic form of a [1,2,4]triazolo[4,3-a]pyridine derivative for treating inflammatory diseases |
| 08/13/2009 | CA2711937A1 Pyrido[4,3-d]pyrimidinone derivatives as kinase inhibitors |
| 08/12/2009 | EP2088149A1 Pharmacologically active n,n'-substituted 3,7-diazabicyclo ý3.3.1¨nonanes, pharmaceutical compositions based thereon and a method for the use thereof |
| 08/12/2009 | EP2086999A1 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof |
| 08/12/2009 | EP2086977A2 Polymorphs of nicotinic intermediates |
| 08/12/2009 | EP2086976A1 Method for producing pradofloxacin |
| 08/12/2009 | EP2086975A2 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods |
| 08/12/2009 | EP2086973A2 Imidazo- and triazolo-pyridine compounds and methods of use therof |
| 08/12/2009 | EP2086972A2 Compounds modulating c-fms and/or c-kit activity and uses therefor |
| 08/12/2009 | EP2086968A1 5-hydroxymethyl-oxazolidin-2-one derivatives |
| 08/12/2009 | EP2086965A1 Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
| 08/12/2009 | EP2086958A2 Substituted-quinoxaline-type-piperidine compounds and the uses thereof |
| 08/12/2009 | EP2086643A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 08/12/2009 | EP2086542A1 Topical formulations |
| 08/12/2009 | EP2086540A1 Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases |
| 08/12/2009 | EP2086539A1 Selective glycosidase inhibitors |
| 08/12/2009 | EP1981886B1 7h-pyrido[3,4-d]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors |
| 08/12/2009 | EP1904461B1 Cyclic anilino-pyridinotriazines as gsk-3 inhibitors |
| 08/12/2009 | EP1899337B1 Process for the preparation of 3,7-diazabicyclo[3.3.1]nonane compounds |
| 08/12/2009 | EP1778686B9 Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors |
| 08/12/2009 | EP1663238B1 HEXA- AND OCTAHYDRO-PYRIDO[1,2-a] PYRAZINE DERIVATIVES WITH NK1 ANTAGONISTIC ACTIVITY |
| 08/12/2009 | EP1427415B1 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 08/12/2009 | EP1385514B9 Spiroindene and spiroindane compounds |
| 08/12/2009 | EP1089988B1 Fluorophenyl resin compounds |
| 08/12/2009 | EP0788360B3 Boronic ester and acid compounds, synthesis and uses |
| 08/12/2009 | CN101506210A 2-phenoxy pyrimidinone analogues |
| 08/12/2009 | CN101506208A Pyrrolo isoquinolines as kinase inhibitors |
| 08/12/2009 | CN101506207A Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element |
| 08/12/2009 | CN101506206A Inhibitors of Akt activity |
| 08/12/2009 | CN101506165A Phenyl, pyridine and quinoline derivatives |
| 08/12/2009 | CN101503407A Imidazopyridine compound |
| 08/12/2009 | CN100526314C Production of high-purity corydalis |
| 08/12/2009 | CN100526313C Imidazopyridine substituted tropane derivatives with CCR5 receptor antagonist activity for the treatment of HIV and inflammation |
| 08/12/2009 | CN100526312C Benzimidazole quinolinones and uses thereof |
| 08/12/2009 | CN100526307C Metalloproteinase inhibitors |
| 08/12/2009 | CN100525768C Novel compounds |
| 08/11/2009 | US7572914 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
| 08/11/2009 | US7572913 Inhibitors of Rho kinase; N-Benzyloxycarbonyl-4-[N''-(tert-butyloxycarbonyl)hydrazino]piperidine; 4-{[N''-(tert-butyloxycarbonyl)-N'-(1'-propyl)]hydrazino}piperidine |
| 08/11/2009 | US7572883 Somatostatin-dopamine chimeric analogs |
| 08/11/2009 | US7572808 2-substituted 7-aryl-[1,2,4]triazolo[4,3-c]pyrimidin-3(2H)-one; mitogen-activated protein kinase inhibitor; physiological and psychotropic effects including regulation of appetite, immunosuppression, analgesia, inflammation, emesis, anti-nocioception, sedation, and intraocular pressure |
| 08/11/2009 | US7572807 3-Cycloheptyl-8-((2,6-dichlorophenoxy)methyl)H-imidazo[1,5-a]pyridine; N-((3-((2,6-Dichlorophenoxy)methyl)pyridin-2-yl)methyl)cycloheptane-carboxamide; diabetes; cardiovascular diseases, Metabolic Syndrome, inflammatory diseases |
| 08/11/2009 | US7572806 PPAR active compounds |
| 08/11/2009 | US7572805 (+-)-cis-6-(Trifluoromethyl)-2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-one hydrochloride; modulation of serotonin receptors; obesity, diabetes, atherosclerosis, dyslipidemia; anxiety, depression, obsessive compulsive disorder, panic disorder, psychosis, schizophrenia, sleep disorder |
| 08/11/2009 | US7572802 For central nervous system diseases, in particular Parkinson's disease, Extra Pyramidal Syndrome, restless legs syndrome and attention deficit hyperactivity disorder |
| 08/11/2009 | US7572801 Pyridopyrimidinone derivatives which are HM74A agonists |
| 08/11/2009 | US7572796 excitatory amino acid antagonists for treating neurodegenerative diseases as cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, cerebral ischaemia, infarction, psychoses; 6-{3-[4-(4-fluorobenzyl)-1-piperidyl]propyl}-1H-indole-3-carbonitrile |
| 08/11/2009 | US7572791 Long-term stability, extended delivery using a suitable reservoir; pumped or metered at a controlled rate; implantable or external pump device, pen style injection device; stable at physiologic temperatures for duration of therapeutic exposure; supply of therapeutically active material for up to 2 years |
| 08/11/2009 | US7572787 Substituted naphthalene sulfonamides |
| 08/11/2009 | CA2482551C 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists |
| 08/11/2009 | CA2395846C Diazepan derivatives or salts thereof |
| 08/11/2009 | CA2222552C N-oxides as antibacterial agents |
| 08/06/2009 | WO2009097515A2 [a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 08/06/2009 | WO2009097287A1 Compounds and compositions as kinase inhibitors |
| 08/06/2009 | WO2009097014A2 Therapeutic kinase modulators |
| 08/06/2009 | WO2009096549A1 Compound having substituted pyridyl group and pyridoindole ring structure linked through phenylene group, and organic electroluminescent device |
| 08/06/2009 | WO2009095752A1 Fused pyrazole derivatives as cannabinoid receptor modulators |
| 08/06/2009 | WO2009095394A1 Diazepanes as histamine h3 receptor antagonists |
| 08/06/2009 | WO2009095253A1 6-halo-pyrazolo[1, 5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mglur) modulators |
| 08/06/2009 | WO2009095162A1 Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/06/2009 | WO2009094831A1 Heteroaromatic compounds, the preparation method and the use thereof |
| 08/06/2009 | WO2009023179A3 Nitrogen containing bicyclic chemical entities for treating viral infections |
| 08/06/2009 | US20090198063 Novel heterocyclic compound or salt thereof and intermediate thereof |
| 08/06/2009 | US20090198061 Camptothecin analogs and methods of preparation thereof |
| 08/06/2009 | US20090198051 Chemical intermediates for sulfiding under mild conditions forming ring compounds for use as marine alkaloids; connecting reaction of 4 components, transforming c22-tert-butyltriphenylsilyl to acety group, cyclization, hydroxy group to methanesulonyl group, reduction of amide, dehydration,Heck reaction |
| 08/06/2009 | US20090198049 Methods and intermediates for the synthesis of porphyrins |
| 08/06/2009 | US20090197965 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 08/06/2009 | US20090197910 Novel viral replication inhibitors |
| 08/06/2009 | US20090197909 Bis-Heterocyclic Imidazolyl Compounds |
| 08/06/2009 | US20090197906 Reversion of malignant phenotype with 9-hydroxy ellipticine derivatives |
| 08/06/2009 | US20090197901 Variolin derivatives and their use as antitumor agents |
| 08/06/2009 | US20090197889 Synthesis and anti-proliferative effect of benzimidazole derivatives |
| 08/06/2009 | US20090197887 Piperazinylpiperidine derivatives as chemokine receptor antagonists |
| 08/06/2009 | US20090197881 pyrrolo[2,3-b]pyridine derivatives used as prostaglandin D2 (PGD2) receptor antagonists, for the treatment of allergic diseases such as asthma |
| 08/06/2009 | US20090197871 Dual Pharmacophores - PDE4-Muscarinic Antagonistics |
| 08/06/2009 | US20090197862 2-aminopyridine kinase inhibitors |
| 08/06/2009 | CA2713807A1 Compounds and compositions as kinase inhibitors |
| 08/06/2009 | CA2712701A1 Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/06/2009 | CA2698463A1 Therapeutic kinase modulators |
| 08/05/2009 | EP2084160A1 Hiv integrase inhibitors |
| 08/05/2009 | EP2084159A1 Pyrido ý2, 3-d¨pyrimidines and their use as kinase inhibitors |
| 08/05/2009 | EP2029559B1 Aryl-4-ethynyl-isoxazole derivatives |
| 08/05/2009 | EP1948132B1 Zolpidem tablets |
| 08/05/2009 | EP1919474B1 Pyrrolopyridine derivatives and use of same as ppar receptor modulators |
| 08/05/2009 | EP1805144A4 Heterocyclical chromophore architectures |
| 08/05/2009 | EP1737459B1 Imidazopyridine and imidazopyrimidine derivatives as antibacterial agents |
| 08/05/2009 | EP1713803B1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments |
| 08/05/2009 | EP1699454B1 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 08/05/2009 | EP1641457B1 Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors |
| 08/05/2009 | EP1465880B1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine |
| 08/05/2009 | EP1401825B1 Thiophene derivatives as antiviral agents for flavivirus infection |
| 08/05/2009 | EP1399445B1 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 08/05/2009 | EP1357111B1 2-pyridone derivatives having affinity for cannabinoid type 2 receptor |
| 08/05/2009 | CN101501034A 1, 7-naphthyridine derivatives as p38 map kinase inhibitors |
| 08/05/2009 | CN101501033A Novel compound having affinity for amyloid |
| 08/05/2009 | CN101501032A Fused, tricyclic sulfonamide inhibitors of gamma secretase |
| 08/05/2009 | CN101501024A Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
| 08/05/2009 | CN101501009A CGRP receptor antagonists |